Noninvasive molecular detection of head and neck squamous cell carcinoma: An exploratory analysis

Diagnostic Molecular Pathology

Volumn 18, Issue 2, 2009, Pages 81-87

  Sethi, Seema ^a   Benninger, Michael S ^a   Lu, Mei ^a   Havard, Shalita ^a   Worsham, Maria J ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Classification and regression tree (CART); Genetic alterations; Head and neck squamous cell carcinoma; Multiplex ligation dependent probe amplification assay (MLPA); Noninvasive

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2B; CYCLIN DEPENDENT KINASE INHIBITOR 2D; DNA METHYLTRANSFERASE 1; EPIDERMAL GROWTH FACTOR RECEPTOR 2; PROTEIN NOXA; PROTEIN P53; PROTEIN TYROSINE PHOSPHATASE 1B; DNA;

ADULT; AGED; ARTICLE; CLASSIFICATION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; DNA EXTRACTION; FEMALE; GENETIC ANALYSIS; GENETIC SCREENING; HEAD AND NECK CARCINOMA; HUMAN; MALE; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; MUTATION; PRIORITY JOURNAL; SALIVA ANALYSIS; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; CHEMISTRY; EVALUATION; GENE FREQUENCY; GENETICS; HEAD AND NECK TUMOR; ISOLATION AND PURIFICATION; MASS SCREENING; METHODOLOGY; MIDDLE AGED; SALIVA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DNA; FEMALE; GENE FREQUENCY; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; SALIVA; YOUNG ADULT;

EID: 67649958108     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/PDM.0b013e3181804b82     Document Type: Article

References (27)

1. Ries LAG HD, Krapcho M, Mariotto A, et al. SEER Cancer Statistics Review, 1975-2003. Bethesda, MD: National Cancer Institute; 2006.
2. American Cancer Society. Cancer Facts and Figures. Atlanta, GA: American Cancer Society; 2006.
3. Forastiere A, Koch W, Trotti A, et al. Head and neck cancer. N Engl J Med. 2001;345:1890-1900.
4. Franzmann EJ, Reategui EP, Carraway KL, et al. Salivary soluble CD44: a potential molecular marker for head and neck cancer. Cancer Epidemiol Biomarkers Prev. 2005;14:735-739.
5. Li Y, St John MA, Zhou X, et al. Salivary transcriptome diagnostics for oral cancer detection. Clin Cancer Res. 2004;10:8442-8450. (Pubitemid 40053408)
6. O'Hara J, Bradley P. Head and neck cancer: a screening strategy. Clin Otolaryngol. 2002;27:133-134. (Pubitemid 34779632)
7. Neville BW, Day TA. Oral cancer and precancerous lesions. CA Cancer J Clin. 2002;52:195-215.
8. Dolan RW, Vaughan CW, Fuleihan N. Symptoms in early head and neck cancer: an inadequate indicator. Otolaryngol Head Neck Surg. 1998;119:463-467. (Pubitemid 28525067)
9. National Cancer Institute. Oral cancers: research report. U.S. Department of Health and Human Services, Public Health Service, NIH 1991; NIH publication no. 92-2876.
10. Sidransky D. Emerging molecular markers of cancer. Nat Rev Cancer. 2002;2:210-219.
11. Choi P, Chen C. Genetic expression profiles and biologic pathway alterations in head and neck squamous cell carcinoma. Cancer. 2005;104:1113-1128. (Pubitemid 41278946)
12. Akervall J. Gene profiling in squamous cell carcinoma of the head and neck. Cancer Metastasis Rev. 2005;24:87-94. (Pubitemid 40576065)
13. Jeon GA, Lee JS, Patel V, et al. Global gene expression profiles of human head and neck squamous carcinoma cell lines. Int J Cancer. 2004;112:249-258. (Pubitemid 39244364)
14. Worsham MJ, Chen KM, Tiwari N, et al. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2006;132:409-415.
15. Boyle JO, Mao L, Brennan JA, et al. Gene mutations in saliva as molecular markers for head and neck squamous cell carcinomas. Am J Surg. 1994;168:429-432. (Pubitemid 24345690)
16. Raju U, Lu M, Sethi S, et al. Molecular classification of breast carcinoma in situ. Curr Genomics. 2006;7:523-532. (Pubitemid 46062383)
17. Chen KM, Sawhney R, Khan M, et al. Methylation of multiple genes as diagnostic and therapeutic markers in primary HNSCC. Arch Otolaryngol Head Neck Surg. 2007;133:1131-1138.
18. Stephen JK, Vaught LE, Chen KM, et al. Epigenetic events underlie the pathogenesis of sinonasal papillomas. Mod Pathol. 2007;20:1-9.
19. Fernandez L, Lapunzina P, Arjona D, et al. Comparative study of three diagnostic approaches (FISH, STRs and MLPA) in 30 patients with 22q11.2 deletion syndrome. Clin Genet. 2005;68:373-378. (Pubitemid 41341617)
20. Douglas J, Tatton-Brown K, Coleman K, et al. Partial NSD1 deletions cause 5% of Sotos syndrome and are readily identifiable by multiplex ligation dependent probe amplification. J Med Genet. 2005;42:56.
21. Bremmer JF, Braakhuis BJ, Ruijter-Schippers HJ, et al. A noninvasive genetic screening test to detect oral preneoplastic lesions. Lab Invest. 2005;85:1481-1488.
22. Schouten JP, McElgunn CJ, Waaijer R, et al. Relative quantification of 40 nucleic acid sequences by multiplex ligation dependent probe amplification. Nucleic Acids Res. 2002;30:e57.
23. Breiman L, Friedman J, Stone CJ. Classification and Regression Trees. New York: Chapman and Hall; 1984.
24. Frankel MR, Morgenstern LB, Kwiatkowski T, et al. Predicting prognosis after stroke: a placebo group analysis from the National Institute of Neurological Disorders and Stroke rt-PA Stroke Trial. Neurology. 2000;55:952-959. (Pubitemid 30764356)
25. Wong DT. Salivary diagnostics powered by nanotechnologies, proteomics and genomics. J Am Dent Assoc. 2006;137:313-321.
26. Miller SM. Saliva testing - a nontraditional diagnostic tool. Clin Lab Sci. 1994;7:39-44.
27. Goutte C. Note on free lunches and cross-validation. Neural Comput. 1997;9:1211-1215.